Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5283139
Max Phase: Preclinical
Molecular Formula: C18H15N5O3S
Molecular Weight: 381.42
Associated Items:
ID: ALA5283139
Max Phase: Preclinical
Molecular Formula: C18H15N5O3S
Molecular Weight: 381.42
Associated Items:
Canonical SMILES: COc1ccc2nc(-c3cn(CCc4ccc([N+](=O)[O-])cc4)nn3)sc2c1
Standard InChI: InChI=1S/C18H15N5O3S/c1-26-14-6-7-15-17(10-14)27-18(19-15)16-11-22(21-20-16)9-8-12-2-4-13(5-3-12)23(24)25/h2-7,10-11H,8-9H2,1H3
Standard InChI Key: INENUHPJVCAUCN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 381.42 | Molecular Weight (Monoisotopic): 381.0896 | AlogP: 3.71 | #Rotatable Bonds: 6 |
Polar Surface Area: 95.97 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 1.00 | CX LogP: 4.37 | CX LogD: 4.37 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.37 | Np Likeness Score: -2.16 |
1. Wongso H, Ono M, Yamasaki T, Kumata K, Higuchi M, Zhang MR, Fulham MJ, Katsifis A, Keller PA.. (2023) Synthesis and structure-activity relationship (SAR) studies of 1,2,3-triazole, amide, and ester-based benzothiazole derivatives as potential molecular probes for tau protein., 14 (5): [PMID:37252097] [10.1039/d2md00358a] |
Source(1):